clinical trial · NCT06949852
Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd·phase3·recruiting·n = 288
Postoperative AnalgesiaNalbuphine Hydrochloride InjectionMorphine Hydrochloride Injection
brief summary
Evaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled intravenous analgesia (PCIA) for the treatment of postoperative analgesia
started
Aug 7, 2024
primary completion
Jun 1, 2025
completion
Mar 1, 2026
last updated
Apr 29, 2025
official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase III Clinical Study to Evaluate the Efficacy and Safety of Nalbuphine Versus Morphine for the Treatment of Postoperative Analgesia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol